Brand-Ad-30-6
 IADVL
Indexed with PubMed and Science Citation Index (E) 
 
Users online: 3088 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
  NAVIGATE Here 
    Next article
    Previous article
    Table of Contents

 RESOURCE Links
    Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
  Related articles
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed16527    
    Printed231    
    Emailed14    
    PDF Downloaded0    
    Comments [Add]    

Recommend this journal

 

 ORIGINAL ARTICLE
Year : 2002  |  Volume : 68  |  Issue : 2  |  Page : 78--81

A comparative clinical study of sisomicin cream versus mupirocin ointment in pyodermas


1 Dept. of Skin, STD & Leprosy, Grant Medical College & Sir J. J. Group of Hospitals J. J. Road, Byculla, Mumbai, India
2 BJ Medical College Pune, India
3 Government Medical College, New Civil Hospital, Surat, India

Correspondence Address:
Chetan Oberai
Dept. of Skin, STD & Leprosy, Grant Medical College & Sir J. J. Group of Hospitals J. J. Road, Byculla, Mumbai
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 17656883

Rights and PermissionsRights and Permissions

This study was designed to compare the efficacy and safety of sisomicin cream (0.1%) or mupirocin ointment (2%) in the treatment of primary or secondary pyodermas requiring topical antibiotic therapy alone. In the evaluable patients (n=290), impetigo was the commonest clinical condition reported. Staphylococcus aureus was the commonest pathogen isolated from the lesons. Both sisomicin and mupirocin treatments produced a steady improvement in the scores of erythema, oedema, vesiculation, pustulation, crusting and scaling but the improvement produced by sisomicin was quicker and more pronounced. The percentage of patients with complete clearing of all lesions was also higher with sisomicin than with mupirocin on days 4, 8 and 14. Patients subjectively rated the sisomicin formulation as excellent in 75% of cases as against 59% with mupirocin. Sisomicin and mupirocin are effective and safe in the management of pyodermas; however sisomicin therapy resulted in faster and greater relief of signs and symptoms.






[FULL TEXT] [PDF Not available]*


        
Print this article     Email this article

Online since 15th March '04
Published by Wolters Kluwer - Medknow